1 In this trial, primary and key secondary endpoints were achieved with RINVOQ 15 mg and a 26-week steroid taper regimen compared to placebo in combination with a 52-week steroid taper regimen.

Zetomipzomib shows 31.3% complete biochemical response with steroid taper to ≤5 mg/day vs. 12.5% on placebo in autoimmune hepatitis patients No disease flares occurred in zetomipzomib-treated ...

“The finding that SGLT-2i and GLP-1RAs lower COPD exacerbation risk compared to DPP-4i suggests these medications could be better options for patients with diabetes and COPD,” Patorno said.

A COPD exacerbation can feel scary in the moment, and it’s natural to experience lingering worry about another flare-up. Having a set of go-to tips can help you mentally cope during — and ...

A recent trial finds an injection given during some asthma and COPD attacks ... point of an exacerbation for this type of asthma has barely changed for over fifty years, with steroid drugs being ...

An injection given during some asthma and COPD attacks ... at the point of an exacerbation for this type of asthma has barely changed for over fifty years, with steroid drugs being the mainstay ...

Although there was no previous formal diagnosis of COPD before his hospital ... transitioned from the IV steroid to oral steroids (Prednisone), complete a prednisone taper, and finish the course ...

Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and ...

About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of ...

Mortality occurred in more patients with severe vs. mild COPD exacerbation based on Rome severity classification. ICU admittance and mechanical ventilation were reported more in the severe group.

The primary outcome was exacerbation of COPD that required hospitalization in a propensity score-matched study. The study population included 356 epilepsy patients, 9411 neuropathic pain patients ...